ABRFX
Price
$16.00
Change
-$0.00 (-0.00%)
Updated
Aug 29 closing price
Net Assets
4.42M
CRAZX
Price
$10.42
Change
+$0.04 (+0.39%)
Updated
Sep 3 closing price
Net Assets
2.47B
Interact to see
Advertisement

ABRFX vs CRAZX

Header iconABRFX vs CRAZX Comparison
Open Charts ABRFX vs CRAZXBanner chart's image
DSS AmericaFirstMonthlyRisk-OnRisk-Off A
Price$16.00
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.42M
Columbia Adaptive Risk Allocation Inst
Price$10.42
Change+$0.04 (+0.39%)
VolumeN/A
Net Assets2.47B
ABRFX vs CRAZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ABRFX vs. CRAZX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABRFX is a Buy and CRAZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CRAZX has more cash in the bank: 2.47B vs. ABRFX (4.42M). CRAZX pays higher dividends than ABRFX: CRAZX (2.31) vs ABRFX (0.00). ABRFX was incepted earlier than CRAZX: ABRFX (16 years) vs CRAZX (13 years). ABRFX (3.81) is less costly to investors than CRAZX (0.81). ABRFX is a more actively managed with annual turnover of: 290.73 vs. CRAZX (186.00). ABRFX has a lower initial minimum investment than CRAZX: ABRFX (1000) vs CRAZX (2000). ABRFX annual gain was more profitable for investors over the last year : 18.43 vs. CRAZX (9.26). ABRFX return over 5 years is better than : 29.55 vs. CRAZX (8.14).
ABRFXCRAZXABRFX / CRAZX
Total Expense Ratio2.880.81356%
Annual Report Gross Expense Ratio3.810.81470%
Fund Existence16 years13 years-
Gain YTD3.4268.91938%
Front Load5%N/A-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets4.42M2.47B0%
Annual Yield % from dividends0.002.31-
Returns for 1 year18.439.26199%
Returns for 3 years34.3423.22148%
Returns for 5 years29.558.14363%
Returns for 10 years41.5936.06115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALIX14.380.06
+0.42%
Value Line Capital Appreciation Investor
IGEAX65.00N/A
N/A
VY® T. Rowe Price Growth Equity A
MGKIX14.60N/A
N/A
Morgan Stanley Global Permanence I
IVRSX27.60N/A
N/A
VY® CBRE Real Estate S
FCDTX36.04N/A
N/A
Fidelity Advisor Stock Selector Sm Cp M